The targeted therapy for immune checkpoint inhibitors (ICI) such as PD-L1 depends on the strong infiltration of T cells in TME, however, the phenotypes of TME such as hypoxia and oxidative stress also influence the function of tumor infiltrating lymphocytes (TIL) [25]. This evidence concerns the gene CD274 and neoplasm.